Why CBD Companies Sink or Swim During COVID-19

What actually is CBD?

CBD stands for cannabidiol, one of the many cannabinoids, or chemical compounds, found in marijuana and hemp. There is another compound found in the cannabis plant named tetrahydrocannabinol, or THC which is its main psychoactive component. CBD, on the other hand, is not psychoactive like THC.

How CBD works?

CBD has been shown in studies to help reduce anxiety in people with schizophrenia or psychosis, as well as those addicted to opiates, in addition to treating epilepsy. CBD’s anti-inflammatory properties may even aid in the treatment of acne. It could also help with arthritis. The Arthritis Foundation was the first major health organization to issue CBD guidelines last fall. Advocates believe there are numerous potential health benefits, but clinicians believe more research is needed.

COVID-19 may have decimated the health of almost everything, from the millions of people who have contracted the disease to the industries and economies that have been impacted. However, early reports indicated that, if nothing else, cannabidiol (CBD) sales were brisk during the pandemic’s early days.

But, as with the coronavirus era, we’re learning about this disease and its market shifts. Moreover, those early reports about CBD sales may no longer be accurate or may have been blips in the data, to begin with. So, now that we’ve had a few months of the new normal, it’s worth looking at how CBD manufacturer are doing now and how they might fare in the future.

A large portion of the research has been conducted using laboratory animals and test tubes. CBD has demonstrated promising antiviral, antibacterial, and other effects in this setting. CBD may also help you sleep and reduce anxiety. However, as the IACM points out, no human studies on CBD’s effects on the coronavirus have been published. There have been numerous reports of a fabricated news story promoting CBD oil as a treatment for the virus that was distributed across the country via texts and social media, directing unsuspecting consumers to a CBD sales site. These false claims touting unproven medical benefits are nothing more than desperate attempts to prey on fearful consumers. Furthermore, it spreads misinformation among consumers who are anxiously looking for ways to stay safe and healthy amid the coronavirus crisis.

During this time of increased focus on wellness and prevention, consumers should be aware that CBD products have not been tested or evaluated by the United States Food and Drug Administration (FDA). Recent research has also discovered the possibility of harmful side effects from consuming cannabis products containing Tetrahydrocannabinol (THC) if a patient is infected with COVID-19. Many unregulated CBD products have been found to contain THC — the primary psychoactive compound in marijuana — although the labels may not disclose this.

COVID-19 has wreaked havoc on the cannabis industry manufacturers, causing highs and lows on a variety of levels. While it is only a matter of time before “normalcy” is restored across all industries, the pandemic’s effects on industrial levels remain a source of concern. However, there is no complete and final assessment of the Cannabis Industry. Consumer stockpiling resulted in a significant increase in revenue for several marijuana dispensaries. Nonetheless, it came down at the same rate as lockdown began to restrict all but essential services.

Parts of cannabis industry boom during COVID

When the pandemic first hit North America, marijuana dispensaries, like most other walk-in retail businesses, closed their doors. Cannabis stocks plummeted as investors worried that companies would lose revenue as a result of lockdown restrictions.

A proactive regulatory approach, on the other hand, saved the day. The industry was quickly deemed an essential business in the United States and Canada, causing cannabis investments to recover faster than the overall stock market – a trend that was bolstered as sales increased and companies innovated. The pandemic has accelerated many business trends, from e-commerce to digital payments. Meanwhile, production and farming have evolved, with greenhouses becoming more technologically advanced than ever before.

While the world will continue to face difficult times in the future, we hope to see innovation and creativity capable of comforting people and fostering businesses. Hopefully, we will see more progress in legally restricted markets, such as those for cannabis-based products.